Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • News & Developments
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • News & Developments
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

Your search for ‘Goodwin Procter LLP’ returned 4,535 results

Use advanced search filters to refine your search

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    PTAB Institutes Mylan's Two EYLEA (Aflibercept) IPRs

    As we previously reported, Mylan recently filed three IPR petitions challenging claims of Regeneron patents directed to treating angiogenic eye disorders with aflibercept...
    United StatesIntellectual Property
    Goodwin Procter LLP
    Goodwin Procter LLP
  • Article

    Regeneron Moves To Terminate Celltrion IPR On Aflibercept Patent After Regeneron Files Statutory Disclaimer

    Last week, Regeneron filed a motion to terminate IPR2023-00620, an IPR filed by Celltrion on February 28, 2023, seeking cancellation of claims 1-4 of Regeneron's U.S. Patent No. 10,406,226 which is generally...
    United StatesIntellectual Property
    Goodwin Procter LLP
    Goodwin Procter LLP
Article

The Future Of Patents For Patients: USPTO Temporarily Extends Cancer Immunotherapy Pilot Program (Patents For Patients) And Requests Public Input On Next Steps

Under the P4P, Applicants can file a petition for expedited examination of a patent application that recites a method of treating cancer using immunotherapy.
United StatesIntellectual Property
Goodwin Procter LLP
Goodwin Procter LLP
  • Article

    USPTO Extends Deadline For Comments On USPTO-FDA Collaboration Initiatives

    On February 24, the USPTO extended the written comment period for Joint USPTO–FDA Collaboration Initiatives until March 10, 2023. As we previously reported, the USPTO requested public input...
    United StatesIntellectual Property
    Goodwin Procter LLP
    Goodwin Procter LLP
  • Article

    USPTO Proposed Rulemaking Regarding Terminal Disclaimers

    The USPTO recently issued a notice of proposed rulemaking regarding terminal disclaimers.
    United StatesIntellectual Property
    Goodwin Procter LLP
    Goodwin Procter LLP
  • Article

    FTC And CFPB Announce $15 Million Settlement Against Credit Reporting Agency For Alleged Inaccuracies In Tenant Screening Reports

    On October 12, 2023, the Federal Trade Commission (FTC) and the Consumer Financial Protection Bureau (CFPB) announced that they filed a joint complaint​ and obtained a $15 million settlement​ against...
    United StatesLitigation, Mediation & Arbitration
    Goodwin Procter LLP
    Goodwin Procter LLP
  • Article

    Industry Stakeholders Raise Concerns Over Fintech Trust Charter Applications

    In October 2025, the Bank Policy Institute (BPI) issued a series of letters opposing efforts by several digital asset and payment firms to secure federal banking charters from the Office of the Comptroller of the Currency (OCC). BPI raised concerns that these companies are seeking trust charters even though, in BPI's view, they will not operate as traditional chartered financial institutions...
    United StatesTechnology
    Goodwin Procter LLP
    Goodwin Procter LLP
  • Article

    CFPB Enters Into $15 Million Settlement With Auto Lender

    On February 23, 2023, the Consumer Financial Protection Bureau (CFPB) announced that it entered into a consent order​ with an auto lender based in Georgia.
    United StatesConsumer Protection
    Goodwin Procter LLP
    Goodwin Procter LLP
  • Article

    Corporate Transparency Act: January 1 Deadline Is Almost Here

    This is a reminder that the due date for Corporate Transparency Act (CTA) filings is approaching. For most companies formed or registered before January 1, 2024, the deadline to file is January 1, 2025.
    United StatesCorporate/Commercial Law
    Goodwin Procter LLP
    Goodwin Procter LLP
  • Article

    CTA Update: FinCEN Clarifies BOI Reporting Requirements For Dissolved Reporting Companies

    Goodwin's Corporate Transparency Act Knowledge Center provides useful resources relating to the Corporate Transparency Act (CTA), including toolkits and supplemental information...
    United StatesCorporate/Commercial Law
    Goodwin Procter LLP
    Goodwin Procter LLP
  • Article

    FCPA Year In Review 2021

    The Foreign Corrupt Practices Act of 1977, as amended, 15 U.S.C. §§ 78dd-1, et seq. (FCPA), makes it unlawful for U.S. persons and entities and others who act within the jurisdiction of the...
    United StatesCorporate/Commercial Law
    Goodwin Procter LLP
    Goodwin Procter LLP
  • Article

    CFPB Abandons Plan To Scrap State Notice Rule

    On July 21, 2025, the CFPB announced that it was withdrawing its planned recission of Section 1082.1 of the Consumer Financial Protection Act (CFPA) implementing regulations, which contains procedures by which state officials must notify the CFPB prior to taking an action enforcing the federal CFPA.
    United StatesFinance and Banking
    Goodwin Procter LLP
    Goodwin Procter LLP
  • Article

    Public Company Advisory News Roundup: SEC Proposes Significant Changes To The Registered Offering Framework

    The latest issue of the Goodwin Public Company Advisory News Roundup has been posted, covering the period from May 11, 2026 – May 21, 2026.
    United StatesCorporate/Commercial Law
    Goodwin Procter LLP
    Goodwin Procter LLP
  • Article

    Private Equity In India: The Risk, Structure And Reward

    With India’s economy showing real GDP growth of 8.7% annually since 2003, international investments into India have increased significantly. Even as market conditions have limited private equity transactions in the United States and, to a certain extent, Europe, private equity investment in India totaled more than $10 billion for all of 2007.
    IndiaFinance and Banking
    Goodwin Procter LLP
    Goodwin Procter LLP
  • Article

    CFPB Asks For Comments On Collecting Information Concerning State Actions Pursuant To Dodd-Frank

    The Consumer Financial Protection Bureau published a notice and request for comment regarding its plans to collect information about legal actions filed by state officials under authority granted in Section 1042(a) of the Dodd-Frank Act.
    United StatesConsumer Protection
    Goodwin Procter LLP
    Goodwin Procter LLP
  • Article

    Anti-Dilution Provisions of Equity Compensation Plans May Need to Be Amended to Avoid Compensation Expenses Under FAS 123(R)

    It has been standard practice for issuers to modify outstanding equity compensation awards in connection with changes in the issuer’s capital structure (such as stock splits, stock dividends, recapitalizations, mergers, consolidations, spin-offs, split-offs and extraordinary cash dividends) in order to preserve the economics of these awards.
    United StatesCorporate/Commercial Law
    Goodwin Procter LLP
    Goodwin Procter LLP
  • Article

    Delaware Decisions Call Into Question Effectiveness Of Advance Notice Bylaws

    Two recent decisions from the Delaware Court of Chancery raise issues concerning the operation of advance notice bylaws.
    United StatesCorporate/Commercial Law
    Goodwin Procter LLP
    Goodwin Procter LLP
  • Article

    Legislation Imposes Additional Obligations on Employers under USERRA

    On March 10, 2005, the U.S. Department of Labor ("DOL") published an interim final rule in the Federal Register which affects private employers.
    United StatesEmployment and HR
    Goodwin Procter LLP
    Goodwin Procter LLP
  • Article

    Patient Protection and Affordable Care Act May Require Cafeteria Plan Amendments by Year End

    The Patient Protection and Affordable Care Act (the "Act"), signed into law by President Obama earlier this year, imposes new requirements on group health plans and flexible spending arrangements that may necessitate Section 125 cafeteria plan amendments and changes in administrative procedures by year end.
    United StatesEmployment and HR
    Goodwin Procter LLP
    Goodwin Procter LLP
  • Article

    CFPB Issues Proposal To Clarify Escrow Rule (Consumer Financial Services Alert - April 16, 2013)

    The CFPB issued a proposal to clarify and make technical amendments to the escrow rule it finalized in January.
    United StatesFinance and Banking
    Goodwin Procter LLP
    Goodwin Procter LLP
  • Showing 821–840 of 4535 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics